NuvaRing® is a vaginal ring contraceptive medication that was approved by the FDA in October 2001. The drug is manufactured by Organon USA, Inc., based in New Jersey, which was acquired by Schering-Plough Corporation in 2007. Since its initial FDA approval and use on the market, NuvaRing® has been linked to serious venous thromboembolic events including blood clots, pulmonary embolism, stroke and myocardial infarction, or heart attack.
 

PROVIGIL is a medication that has the active ingredient of Modanifil and is used to treat excessive sleepiness caused by certain sleep disorders. These sleep disorders are narcolepsy, obstructive sleep apnea/hypopnea syndrome, and shift work sleep disorder. In addition to its wakefulness-promoting effects, PROVIGIL produces psychoactive and euphoric effects, alterations in mood, perception, thinking, and feelings typical of other central nervous system stimulants.

On October 14, 2007, Medtronic, the nation's largest heart implant device manufacturer, announced a defect in the critical electrical "lead" component of its heart defibrillator. The New York Times reported on October 15, 2007, that the defect in this electrical wire, called the Sprint Fidelis, has resulted in hundreds of malfunctions and may have

Specific lot numbers of the Composix® Kugel® Mesh Patches, used to repair ventral (incisional) hernias caused by thinning and stretching of scar tissue post-surgery, were recently recalled by manufacturer Davol, Inc., a subsidiary of C.R. Bard, Inc. The recall occurred after it was discovered that the "memory recoil ring," which opens the patch, can break under the stress of placement in the intra-abdominal space. This can lead to serious intestinal conditions such as bowel perforations and/or chronic intestinal fistulae (abnormal connections or passageways between the intestines and other organs).
 

The N.J. Prescription Drug Retail Price Registry will help consumers compare the retail prices charged by many pharmacies for the 150 most frequently prescribed prescription drugs.

Following pleas from state health officials after the Centers for Disease Control linked at least 165 cases of Salmonella in 31 states to ConAgra produced pot pies, the company finally recalled the products on Thursday, October 11, 2007.

TAINTED TISSUE AND BONES USED IN TRANSPLANTS 

New Report Reveals That Medicare is Covering $23 Billion in Medical Costs That Should be Paid by Workers' Compensation --$4.2 Billion Halliburton Asbestos Settlement Given Final Approval by Court -- Recent Court Decisions: Dinner Not A Deviation from Employment (NJ Supreme Court) -- Remicade linked to severe hepatic reactions, including acute liver failure, jaundice, hepatitis and cholestasis. -- 2nd Annual This Year in Workers' Compensation - The Top Issues and Cases - March 8, 2005 -- Medicare Secondary Payer Act - Waivers and Compromises CMS -- Social Security Announces 2.7 Percent Benefit Increase for 2005 Monthly Social Security and Supplemental -- FDA Statement on the Halting of a Clinical Trial of the Cox-2 Inhibitor Celebrex  

 Vioxx was voluntarily recalled on September 30, 2004, by drug giant Merck following information that people taking Vioxx are twice as likely to have heart attacks and strokes as people who take older anti-inflammatory drugs, such as naproxen. 

We are now investigating claims involving Serzone® (nefazodone), an old line anti-depressant drug approved by the Food and Drug Administration in 1994. Last week, drug maker Bristol-Myers, Squib Co. announced it would pull this drug off the market with distribution to end on June 14. Even though Bristol-Myers blamed lagging sales as the reason, the facts are that Serzone® is blamed for dozens of cases of liver toxicity, resulting in liver failure, death or transplantation.

New Jersey lawyers choose the tops in their profession in 24 fields of law.

What is the Gnidant Ancure Endograft System? The Ancure Devise was designed for use in the treatment of abdominal aortic aneurysms. An abdominal aortic aneurysm is a potentially life threatening condition involving a weak area that develops in the wall of the aorta, the artery that brings blood flow from the heart through the abdomen to the rest of the body. The Aneure Device sold by Guidant has two primary parts. 

In August one of the first cases was filed against the manufacturer of the biological product, Enbrel (etanercept). Enbrel (etanercept) was approved by the U.S. Food and Drug Administration on November 2, 1998, as a second-line agent for the treatment of juvenile rheumatoid arthritis. At the time Enbrel was co-marketed by Immunex, Corp. 

Remicade (Infliximab) is an immune-suppressing product manufactured by Centocor, a wholly owned subsidiary of Johnson & Johnson, which has been approved by the U.S. Food and Drug Administration for the use for Crohn's disease and rheumatoid arthritis. Remicade is a worldwide market share leader among tumor necrosis factor alpha therapies and is the only biologic drug indicated for the treatment of both Rheumatoid Arthritis and Crohns' disease.

 Centocor October 18, 2001 IMPORTANT DRUG WARNING Dear Healthcare Professional: Centocor, Inc. would like to inform you of important new safety...

On October 14, 2007, Medtronic, the nation's largest heart implant device manufacturer, announced a defect in the critical electrical "lead" component of its heart defibrillator. The New York Times reported on October 15, 2007, that the defect in this electrical wire, called the Sprint Fidelis, has resulted in hundreds of malfunctions and may have played a role in the death of five Medtronic defibrillator patients.